>Chem 1 >Ok anon you have to follow the sig fig rules precisely or else you'll get the wrong answer. >But what about roundoff error? >Don't worry about that, it corrects itself.
>Quantitative Analysis >Anon it's good practice to hold onto several insignificant figures while doing calculations, it strongly reduces roundoff error.
Why is half of everything I learn end up being a fucking self defeating meme?
Scientists say that the Andromeda galaxy is on a collision course with the Milky Way galaxy. OK. Now if there really was a really big boom that created the universe, how can this be? Shouldn't all galaxies be moving in the same direction?
He doesn't consier 99% interactions with other people as a waste of time (or just onerous chores), that could be utilized to understand the nature of reality better.
What is the difference between my brain calculating a response to the input it is receiving and a computer performing some calculation?
If there was a being that understood every process occurring within my brain he would be able to calculate what I’ll do before I do it. And it would be trivial to him.
Furthermore, the response my brain produces is purely a result of the input that is given to it. Similarly with a computer.
So why should I not assume that a computer has some subjective conscious experience?
Can we all agree (climate alarmist and anthro-climate change deniers alike) that nuclear power is both the cleanest and most reliable source of power? For climate change people it’s probably your best hope to slow runaway effects of carbon release. For deniers, nuclear just makes sense because of reliability, air quality etc. So why can’t both sides agree on a nuclear power economy. Why can’t any government commission contestants to build Competing reactor designs and select a winner to standardize and create a supply chain for commodification and economies of scale?
There's not a lot of money to be made in studying dietary supplements, and my hat is off to the physicians and scientists who conducted the first randomized, double-blinded prospective trial of ARG in hospitalized COVID-19 patients in Italy (with collaboration from the Albert Einstein College of Medicine). Near as I can gather, they received no funding for their efforts, which are groundbreaking and deserving of international recognition and gratitude.
Let's start with the exciting stuff: the trial showed a statistically significant difference in secondary endpoint comprising hospital length of stay (LOS). Median LOS was 25 days in the ARG group compared to 46 days in the placebo group (P<0.0001). The primary endpoint was designed as reduction of respiratory support, which was also statistically significantly improved among the ARG group at day 10 (with an odds ratio of 6.6, P=0.01), but lost significance at day 20. Having said that, the authors note that this apparent attrition of benefit may actually reveal attrition of illness: a very large number of the ARG group had already healed/been discharged, enriching the proportion of the sickest in that arm.
